With promising mid-stage trial results, berobenatide aims to make obesity treatment more convenient without compromising ...

The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this ...

Pfizer's experimental drug, berobenatide, is designed to stay attached longer to a blood protein called albumin, helping prevent it from breaking down too quickly.

Obesity has become a growing concern worldwide, and GLP-1 drugs have brought relief to millions struggling with weight ...

PFE is betting on monthly obesity treatments and new oral programs to challenge LLY and NVO in a market projected to hit $120 billion by 2035.

See more Winnipeg Sun on Google - save as a Preferred Source ...

An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial. The results were ...

Searching for a weight-loss drug but don't like the idea of an injection? Pfizer may soon be able to help. The pharmaceutical company announced Thursday it's advancing development of its GLP-1 ...